AA
48
-12
VRSN
53
-4
CMA
61
5
LMT
34
2
R
71
4
EFX
38
2
PFE
23
7
DOW
44
10
M
37
12
XRX
44
3
PFG
45
3
BWA
48
2
NOC
43
11
MAT
46
12
GT
62
6
ROP
62
3
GPC
40
3
LEG
36
4
KLAC
47
4
PM
62
-2
AA
48
-12
VRSN
53
-4
CMA
61
5
LMT
34
2
R
71
4
EFX
38
2
PFE
23
7
DOW
44
10
M
37
12
XRX
44
3
PFG
45
3
BWA
48
2
NOC
43
11
MAT
46
12
GT
62
6
ROP
62
3
GPC
40
3
LEG
36
4
KLAC
47
4
PM
62
-2
Financhill
Back

Verve Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25

VERV
Verve Therapeutics

Last Price:
4.85
Seasonality Move:
-11.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Verve Therapeutics Price Quote

$4.85

Verve Therapeutics Key Stats

Sell
25
Verve Therapeutics (VERV) is a Sell
Day range:
$4.50 - $4.87
52-week range:
$4.31 - $19.34
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
16.60
P/B ratio:
0.81%
Volume:
1.1M
Avg. volume:
1.4M
1-year change:
-59.72%
Market cap:
$410.6M
Revenue:
$11.8M
EPS:
$-2.46

How Much Does Verve Therapeutics Make?

Is Verve Therapeutics Growing As A Company?

  • What Is Verve Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.2%
  • What Is Verve Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Verve Therapeutics Stock Price Performance

What Is Verve Therapeutics 52-Week High & Low?

Verve Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Verve Therapeutics?

Is Verve Therapeutics Cash Flow Positive?

  • What Is VERV Cash Flow From Operations?
    Cash flow from operations (TTM) is -$157.5M
  • What Is Verve Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $201.4M
  • What Is Verve Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $36.4M

Verve Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    VERV return on invested capital is -36.52%
  • What Is Verve Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -28.45%
  • What Is VERV Return On Equity?
    ROE is a measure of profitability and is -36.52%

Verve Therapeutics Earnings Date & Stock Price

Verve Therapeutics Competitors

Verve Therapeutics Dividend Yield

Verve Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 14.2%
Revenue: 120.24% 110.87%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 26.20
Upside from Last Price: 440.25%

Major Shareholders

  • How many VERV shares are owned by institutional investors?
    113.5M VERV shares are owned by institutional investors
  • How many VERV shares are owned by insiders?
    1.2M VERV shares are owned by insiders